In a recent study, it was found that PIAS3 acts at least in part via SUMOylation of Smurf2 to suppress the invasive growth of breast cancer cell-derived organoids suggesting a potential anti-metastatic activity of SUMOylated-Smurf2 [57] (Figure 3 and Figure 4). This evidence concerns the gene SMURF2 and breast carcinoma.